Innotrac was founded in 1995 and the company premises are located at the technology center of Turku, Finland. The company started as OEM manufacturer and has expanded it’s activities into R&D having currently about 70 employees (of which 15 chemists or biochemists).The core management team has long experience in the in vitro diagnostics industry. The company has a close research co-operation with the University of Turku and other research institutions in Finland and Scandinavia. The company is ISO 9001:2000 and ISO 13485:2003 certified.

First Innotrac products - Innotrac Aio! Satellite together with three AMI analytes; troponin I, CK-MB (mass) and myoglobin – were launched in Finland in February 2001. The worldwide launch proceeded from March 2001 onwards.

2006 Innotrac was acquired by Radiometer A/S, and the all-in-one chemistry technology was brought into Radiometer instrument platform. Rapid, high quality results in cardiac and critical care diagnostics were combined with instrument development & marketing knowhow & extensive sales channels of Radiometer.
AQT90 Flex immunoassays are based on the Innotrac Diagnostics proprietary all-in-one dry chemistry and on the proven time-resolved fluorescence technology. All immunoassays have been developed and optimized at Innotrac Diagnostics.

The first chemistry products launched for AQT90 Flex in 2008 are used for the rapid detection of myocardial infarction in Point-Of-Care. At the moment there are tests available for 8 analytes; cardiac markers, infection markers and pregnancy markers ; more information of the analytes.

The AQT90 Flex cup contains all analyte specific components which are needed to perform an immunoassay. Sample material can be whole blood, plasma or serum. Quantitative results are available within 15 minutes of sample taking.
Innotrac Diagnostics Oy :: Biolinja 12 :: FIN-20750 TURKU :: VAT FI 10320534 :: Tel. +358-2-278 4000 :: Fax +358-2-278 4001 :: info@radiometer.fi